Common adverse drug reactions associated with<unk>  therapy include: *Cardiovascular: low blood pressure, high blood pressure, swelling *Central nervous system: insomnia *Dermatological: rash *Gastrointestinal: diarrhea, abdominal pain *Hematological: eosinophilia *Respiratory: dyspnea *Other: injection site reactions, fever, hypersensitivity Less common, but serious adverse events reported in the literature include *Hepatotoxicity: elevated transaminases *Nephrotoxicity: acute kidney injury from rhabdomyolysis Also, myopathy and rhabdomyolysis have been reported in patients simultaneously taking statins, but whether this is due entirely to the statin or whether<unk>  potentiates this effect is unknown. Due to the limited data available, the manufacturer recommends that statins be temporarily discontinued while the patient is receiving<unk>  therapy. Creatine kinase levels are usually checked regularly while individuals undergo<unk>  therapy. In July 2010, the FDA issued a warning that<unk>  could cause life-threatening eosinophilic pneumonia. The FDA said it had identified seven confirmed cases of eosinophilic pneumonia between 2004 and 2010 and an additional 36 possible cases. The seven confirmed victims were all older than 60 and symptoms appeared within two weeks of initiation of therapy.
Daptomycin
Teicoplanin
Resistin
Colistin
Linezolid
Vancomycin
Minocycline
Sarecycline